July 2021 Price Hikes Methodology
P4AD analyzed the wholesale acquisition cost (WAC) data for the 170 unique National Drug Codes (NDCs) with price hikes greater than 1% or $1 that were posted between July 1 and July 6.
New Report Reveals Big Pharma’s Influence On Patient Advocacy Groups
Pharmaceutical Industry’s Financial Power And Influence Remain Strong And Far-Reaching As Drug Pricing Legislation Moves Forward
The problem is the price: 5 reasons the cystic fibrosis community and its allies must band together to speak out about our drug prices – right now.
But I live in fear that we won’t be able to afford his medication from Vertex. I live in fear that stock buybacks and CEO pay raises will come before lowering the price of Eli’s drugs. That’s why I decided to fight back. That’s why I’m calling on all shareholders and the cystic fibrosis community to demand Vertex use its windfall in corporate tax breaks to lower the price of Cystic Fibrosis drugs.
Drug Prices are Putting My Son’s Health at Risk
This terrible federal policy, and these drug prices, put my son’s health at grave risk. How long can the system continue to absorb these kinds of costs?
Stacy’s Story
Abbvie made moves recently to ensure no generic versions will enter the market for at least five more years. The impact of these maneuvers translates to $15,000 for us, money we could use for retirement, or my son’s college fund.
Can I tell you a story?
I'm Pam Holt, and I have cancer. I had to take on $10,000 in debt to pay for Revlimid. But, I told myself, the company needed this money for research. I was wrong. This is what I just did about it:
